- Home
- PFO vs BDSX Comparison
PFO vs BDSX Comparison
Compare PFO & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- BDSX
- Stock Information
- Founded
- PFO 1991
- BDSX 2005
- Country
- PFO United States
- BDSX United States
- Employees
- PFO N/A
- BDSX N/A
- Industry
- PFO Finance Companies
- BDSX Precision Instruments
- Sector
- PFO Finance
- BDSX Health Care
- Exchange
- PFO Nasdaq
- BDSX Nasdaq
- Market Cap
- PFO 116.6M
- BDSX 115.4M
- IPO Year
- PFO N/A
- BDSX 2020
- Fundamental
- Price
- PFO $9.33
- BDSX $0.28
- Analyst Decision
- PFO
- BDSX Strong Buy
- Analyst Count
- PFO 0
- BDSX 5
- Target Price
- PFO N/A
- BDSX $1.75
- AVG Volume (30 Days)
- PFO 31.8K
- BDSX 1.8M
- Earning Date
- PFO 01-01-0001
- BDSX 08-06-2025
- Dividend Yield
- PFO 6.51%
- BDSX N/A
- EPS Growth
- PFO N/A
- BDSX N/A
- EPS
- PFO N/A
- BDSX N/A
- Revenue
- PFO N/A
- BDSX $74,463,000.00
- Revenue This Year
- PFO N/A
- BDSX $17.29
- Revenue Next Year
- PFO N/A
- BDSX $29.33
- P/E Ratio
- PFO N/A
- BDSX N/A
- Revenue Growth
- PFO N/A
- BDSX 35.76
- 52 Week Low
- PFO $6.90
- BDSX $0.17
- 52 Week High
- PFO $8.51
- BDSX $2.04
- Technical
- Relative Strength Index (RSI)
- PFO 72.81
- BDSX 42.55
- Support Level
- PFO $9.12
- BDSX $0.25
- Resistance Level
- PFO $9.23
- BDSX $0.31
- Average True Range (ATR)
- PFO 0.07
- BDSX 0.02
- MACD
- PFO 0.01
- BDSX 0.01
- Stochastic Oscillator
- PFO 89.19
- BDSX 40.00
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.